CreativeOne Wealth LLC increased its position in The Procter & Gamble Company (NYSE:PG - Free Report) by 50.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 33,121 shares of the company's stock after buying an additional 11,041 shares during the quarter. CreativeOne Wealth LLC's holdings in Procter & Gamble were worth $5,736,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. International Assets Investment Management LLC grew its stake in shares of Procter & Gamble by 19,030.8% in the third quarter. International Assets Investment Management LLC now owns 3,693,593 shares of the company's stock worth $639,730,000 after purchasing an additional 3,674,286 shares during the last quarter. Wulff Hansen & CO. grew its position in shares of Procter & Gamble by 16,292.0% in the 2nd quarter. Wulff Hansen & CO. now owns 3,675,902 shares of the company's stock worth $606,230,000 after buying an additional 3,653,477 shares during the last quarter. B. Metzler seel. Sohn & Co. Holding AG purchased a new position in shares of Procter & Gamble during the third quarter valued at approximately $301,950,000. AMF Tjanstepension AB raised its holdings in shares of Procter & Gamble by 416.1% during the third quarter. AMF Tjanstepension AB now owns 1,818,490 shares of the company's stock valued at $315,016,000 after acquiring an additional 1,466,115 shares in the last quarter. Finally, Swedbank AB purchased a new stake in Procter & Gamble in the first quarter worth $233,788,000. 65.77% of the stock is currently owned by institutional investors.
Procter & Gamble Stock Performance
PG stock opened at $179.49 on Wednesday. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The Procter & Gamble Company has a 1 year low of $142.50 and a 1 year high of $179.49. The company has a market cap of $422.71 billion, a P/E ratio of 30.92, a price-to-earnings-growth ratio of 3.82 and a beta of 0.42. The stock's fifty day moving average price is $170.11 and its 200-day moving average price is $168.83.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The business had revenue of $21.74 billion for the quarter, compared to analysts' expectations of $21.99 billion. During the same period last year, the firm posted $1.83 earnings per share. The business's revenue for the quarter was down .6% on a year-over-year basis. On average, equities analysts forecast that The Procter & Gamble Company will post 6.96 earnings per share for the current year.
Procter & Gamble Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were paid a $1.0065 dividend. The ex-dividend date of this dividend was Friday, October 18th. This represents a $4.03 annualized dividend and a dividend yield of 2.24%. Procter & Gamble's dividend payout ratio (DPR) is 69.48%.
Insider Buying and Selling
In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of Procter & Gamble stock in a transaction that occurred on Thursday, October 24th. The shares were sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the transaction, the insider now owns 11,566 shares of the company's stock, valued at $1,954,538.34. The trade was a 52.53 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Jon R. Moeller sold 7,007 shares of the stock in a transaction on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total transaction of $1,202,751.55. Following the completion of the sale, the chief executive officer now directly owns 269,172 shares of the company's stock, valued at approximately $46,203,373.80. This trade represents a 2.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 35,233 shares of company stock valued at $6,024,234. 0.18% of the stock is owned by company insiders.
Analysts Set New Price Targets
Several research analysts have commented on the stock. Dbs Bank cut shares of Procter & Gamble from a "strong-buy" rating to a "hold" rating in a research report on Thursday, August 1st. Evercore ISI raised their price objective on shares of Procter & Gamble from $180.00 to $183.00 and gave the stock an "outperform" rating in a report on Monday, October 21st. Hsbc Global Res raised Procter & Gamble to a "strong-buy" rating in a research report on Friday, October 4th. Barclays lowered Procter & Gamble from an "overweight" rating to an "equal weight" rating and set a $163.00 target price for the company. in a research report on Monday, September 30th. Finally, JPMorgan Chase & Co. lifted their price target on Procter & Gamble from $179.00 to $186.00 and gave the company an "overweight" rating in a research report on Thursday, September 19th. Eight research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $180.45.
Check Out Our Latest Report on PG
About Procter & Gamble
(
Free Report)
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report